Enliven Therapeutics (ELVN)
Develops small-molecule therapies centered on ELVN-001 for chronic myeloid leukemia.
$46.10
vs last close−2.09 (−4.34%)
Something off on this page? Send us feedback.
Next report
Nov 11, 26
estimated · in 49 days
EPS estimate
−$0.43
Revenue estimate
—
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$0.46−$0.57−$0.49−$0.32−$0.48−$0.38−$0.49Pending
Estimate−$0.53−$0.51−$0.53−$0.43−$0.42−$0.44−$0.39−$0.43
Surprise+13.2%−11.8%+7.5%+25.6%−14.3%+13.6%−26.6%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported———————Pending
Estimate———$8.3K$12.5K———
Surprise————————
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2028 | −$0.72 | — | — |
| Sep 2028 | −$0.69 | — | — |
| Jun 2028 | −$0.65 | — | — |
| Mar 2028 | −$0.62 | — | — |
| Dec 2027 | −$0.61 | — | — |
| Sep 2027 | −$0.57 | — | — |
| Jun 2027 | −$0.57 | — | — |
| Mar 2027 | −$0.50 | — | — |
| Dec 2026 | −$0.52 | — | — |
| Nov 2026 | −$0.43 | — | — |
| Aug 2026 | −$0.39 | −$0.49 | −26.6% |
| May 2026 | −$0.44 | −$0.38 | +13.6% |
| Mar 2026 | −$0.42 | −$0.48 | −14.3% |
| Nov 2025 | −$0.43 | −$0.32 | +25.6% |
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Oct 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Dec 2019 | |||
| Mar 2020 | |||
| Jun 2019 | |||
| Mar 2019 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2028 | −$0.72 | — | — | $0 | — | — | — |
| Sep 2028 | −$0.69 | — | — | $0 | — | — | — |
| Jun 2028 | −$0.65 | — | — | $0 | — | — | — |
| Mar 2028 | −$0.62 | — | — | $0 | — | — | — |
| Dec 2027 | −$0.61 | — | — | $0 | — | — | — |
| Sep 2027 | −$0.57 | — | — | $0 | — | — | — |
| Jun 2027 | −$0.57 | — | — | $0 | — | — | — |
| Mar 2027 | −$0.50 | — | — | $0 | — | — | — |
| Dec 2026 | −$0.52 | — | — | $0 | — | — | — |
| Nov 11, 2026 | −$0.43 | — | — | $0 | — | — | — |
| Aug 5, 2026 | −$0.39 | −$0.49 | −26.6% | — | — | — | +1.0% |
| May 7, 2026 | −$0.44 | −$0.38 | +13.6% | — | — | — | −2.2% |
| Mar 3, 2026 | −$0.42 | −$0.48 | −14.3% | $12.5K | — | — | −2.5% |
| Nov 12, 2025 | −$0.43 | −$0.32 | +25.6% | $8.3K | — | — | +3.4% |
| Aug 13, 2025 | |||||||
| May 14, 2025 | |||||||
| Mar 13, 2025 | |||||||
| Nov 13, 2024 | |||||||
| Aug 13, 2024 | |||||||
| May 14, 2024 | |||||||
| Mar 14, 2024 | |||||||
| Nov 9, 2023 | |||||||
| Aug 10, 2023 | |||||||
| May 11, 2023 | |||||||
| Feb 10, 2023 | |||||||
| Oct 25, 2022 | |||||||
| Aug 3, 2022 | |||||||
| May 6, 2022 | |||||||
| Mar 15, 2022 | |||||||
| Nov 9, 2021 | |||||||
| Aug 6, 2021 | |||||||
| May 11, 2021 | |||||||
| Mar 5, 2021 | |||||||
| Nov 5, 2020 | |||||||
| Aug 14, 2020 | |||||||
| May 7, 2020 | |||||||
| Dec 31, 2019 | |||||||
| Mar 11, 2020 | |||||||
| Jun 30, 2019 | |||||||
| Mar 31, 2019 |